Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arbor Realty Trust F Pref | ABR-F | Jan 23, 2025 | 22.25 | +0.05 |
Arbutus Biopharma | ABUS | Jan 23, 2025 | 3.34 | +3.73 |
Arcadia Biosciences | RKDA | Jan 23, 2025 | 5.27 | +1.35 |
Arcadium Lithium | ALTM | Jan 23, 2025 | 5.73 | 0.00 |
ArcBest | ARCB | Jan 23, 2025 | 100.23 | +1.79 |
Arcellx | ACLX | Jan 23, 2025 | 65.39 | -0.70 |
Arcelor Mittal ADR | MT | Jan 23, 2025 | 24.00 | +3.05 |
Arch Capital F Pref | ACGLO | Jan 23, 2025 | 21.88 | -0.39 |
Arch Capital G | ACGLN | Jan 23, 2025 | 18.72 | 0.00 |
Arch Capital Group | ACGL | Jan 23, 2025 | 93.02 | -0.20 |
Arch Resources A | ARCH | Jan 23, 2025 | 134.83 | 0.00 |
Archer Aviation A | ACHR | Jan 23, 2025 | 9.89 | +1.23 |
Archer Daniels Midland | ADM | Jan 23, 2025 | 50.66 | +0.28 |
Archrock | AROC | Jan 23, 2025 | 29.60 | -0.50 |
Arcos Dorados | ARCO | Jan 23, 2025 | 7.20 | -1.77 |
Arcosa | ACA | Jan 23, 2025 | 100.38 | +0.24 |
Arcturus Therapeutics | ARCT | Jan 23, 2025 | 17.42 | +4.06 |
Arcus Biosciences | RCUS | Jan 23, 2025 | 13.33 | -0.52 |
Arcutis Biotherapeutics | ARQT | Jan 23, 2025 | 13.60 | -0.80 |
Ardagh Metal Packaging | AMBP | Jan 23, 2025 | 2.79 | 0.00 |
Ardelyx | ARDX | Jan 23, 2025 | 5.51 | +9.11 |
Ardent Health Partners | ARDT | Jan 23, 2025 | 15.25 | +4.88 |
Ardmore Shipping | ASC | Jan 23, 2025 | 11.54 | +1.14 |
Ares Acquisition II | AACT | Jan 23, 2025 | 11.01 | -0.05 |
Ares Capital | ARCC | Jan 23, 2025 | 23.38 | 0.00 |
Ares Commercial Real Estate | ACRE | Jan 23, 2025 | 5.68 | -0.87 |
Ares Dynamic Credit Allocation Fund | ARDC | Jan 23, 2025 | 15.19 | +0.20 |
Ares Management A | ARES | Jan 23, 2025 | 195.90 | +1.08 |
Ares Management Pref B | ARES-B | Jan 23, 2025 | 60.13 | 0.00 |
Argan | AGX | Jan 23, 2025 | 174.92 | -4.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.